World Health Organization OKs Multi-dose Maternal RSV Vaccine
The new multi-dose RSV vial is expected to lower costs and simplify global distribution to protect infants from severe respiratory illness.
The new multi-dose RSV vial is expected to lower costs and simplify global distribution to protect infants from severe respiratory illness.
Patients with severe asthma show structural brain changes and altered neural communication pathways linked to chronic inflammation.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
AAP recommendations expand second-season RSV protection criteria for children ages 8 to 19 months, alongside updated infant COVID-19 vaccination recommendations.
Rapid, noninvasive ultrasound scan of the thigh can identify cardiac surgery patients at elevated risk of serious pulmonary complications before symptoms appear.
Targeting key cellular proteins may provide new opportunities to diagnose, prevent, and treat pulmonary arterial hypertension.
People with a COVID-19 history showed a significantly stronger breathing response following brief arousals from sleep.